Novo Nordisk A/S Common Stock (NVO)
Other Income/Expenses (Net)
-kr 186.00M
Quarterly · Period ending: · DKK
NVO Other Income/Expenses (Net)
Latest reported-kr 186.00M DKKperiod ending
Latest reported-kr 186.00M DKKperiod ending
NVO Quarterly Other Income/Expenses (Net) · DKK (-kr 985.86M → -kr 186.00M)
Quarterly Other Income/Expenses (Net)
High-resolution chart · PNG
NVO other income/expenses (net) history
Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (DKK) |
|---|---|
| -5,745,676,000 | |
| -5,346,381,000 | |
| 14,405,858,000 | |
| -15,344,603,000 | |
| -6,484,813,000 | |
| -5,562,917,000 | |
| 11,766,649,000 | |
| -5,823,171,000 | |
| -5,022,575,000 | |
| -4,631,290,000 | |
| 10,967,771,000 | |
| -5,034,765,000 | |
| -4,568,091,000 | |
| -4,192,679,000 | |
| 9,962,308,000 | |
| -4,315,842,000 | |
| -4,124,682,000 | |
| -3,627,146,000 | |
| 8,722,527,000 | |
| -3,669,035,000 | |
| -3,507,569,000 | |
| -3,434,748,000 | |
| 8,429,582,000 | |
| -3,217,961,000 | |
| -3,573,302,000 | |
| -3,370,631,000 | |
| 8,120,598,000 | |
| -3,374,955,000 | |
| -3,423,015,000 | |
| -3,111,335,000 | |
| 6,960,188,000 | |
| -3,131,167,000 | |
| -3,003,501,000 | |
| -2,626,239,000 | |
| 6,798,086,000 | |
| -2,565,661,000 | |
| -2,809,229,000 | |
| -2,661,793,000 | |
| 5,481,116,000 | |
| -2,392,853,000 | |
| -2,248,956,000 | |
| -2,276,338,000 | |
| 4,953,559,000 | |
| -2,029,455,000 | |
| -2,031,634,000 | |
| -1,940,479,000 | |
| 4,424,324,000 | |
| -1,747,800,000 | |
| -1,757,120,000 | |
| -1,975,761,000 | |
| 3,057,706,000 | |
| -1,320,282,000 | |
| -1,387,077,000 | |
| -1,187,376,000 | |
| 2,996,802,000 | |
| -1,271,250,000 | |
| -1,167,516,000 | |
| -1,227,832,000 | |
| 2,474,194,000 | |
| -1,014,592,000 | |
| -1,109,964,000 | |
| -1,025,543,000 | |
| 2,383,778,000 | |
| -985,861,500 |